The estimated Net Worth of Ranga C Krishna is at least 400 千$ dollars as of 7 August 2012. Dr Krishna owns over 50,000 units of IGC Pharma Inc stock worth over 400,139$ and over the last 13 years he sold IGC stock worth over 0$.
Dr has made over 3 trades of the IGC Pharma Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he bought 50,000 units of IGC stock worth 10,000$ on 7 August 2012.
The largest trade he's ever made was buying 976,961 units of IGC Pharma Inc stock on 10 August 2011 worth over 205,162$. On average, Dr trades about 355,820 units every 121 days since 2011. As of 7 August 2012 he still owns at least 1,068,461 units of IGC Pharma Inc stock.
You can see the complete history of Dr Krishna stock trades at the bottom of the page.
Dr. Ranga C. Krishna M.D. is the Sr. Advisor at IGC Pharma Inc.
Dr D is 57, he's been the Sr. Advisor of IGC Pharma Inc since . There are 2 older and 4 younger executives at IGC Pharma Inc. The oldest executive at IGC Pharma Inc is Richard Prins, 62, who is the Independent Chairman of the Board.
Ranga's mailing address filed with the SEC is 330 THORNTON ROAD, , ENGLEWOOD, X1, 07631.
Over the last 17 years, insiders at IGC Pharma Inc have traded over 12,397,736$ worth of IGC Pharma Inc stock and bought 1,543,722 units worth 473,972$ . The most active insiders traders include Ram Mukunda、Steven Michael Oliveira、Zwirn & Co., L.P.Zwirn Dani.... On average, IGC Pharma Inc executives and independent directors trade stock every 143 days with the average trade being worth of 93,624$. The most recent stock trade was executed by Ram Mukunda on 13 March 2024, trading 1,184,585 units of IGC stock currently worth 443,627$.
igc is developing a product portfolio of phytocannabinoid-based therapies through leading edge research for the treatment of a wide range of therapeutic indications. these include neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis, which are life altering or life threatening our mission is to treat pain, ptsd, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions with phytocannabinoid-based treatments
IGC Pharma Inc executives and other stock owners filed with the SEC include: